Crossmark Global Holdings’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
727,194
+330,361
| +83% | +$5.11M | 0.18% | 135 |
|
|
2025
Q1 | $5.9M | Buy |
396,833
+186,349
| +89% | +$2.77M | 0.1% | 217 |
|
|
2024
Q4 | $2.79M | Buy |
210,484
+155,795
| +285% | +$2.06M | 0.05% | 327 |
|
|
2024
Q3 | $778K | Buy |
54,689
+20,055
| +58% | +$285K | 0.01% | 691 |
|
|
2024
Q2 | $448K | Buy |
34,634
+486
| +1% | +$6.29K | 0.01% | 884 |
|
|
2024
Q1 | $474K | Sell |
34,148
-1,517
| -4% | -$21.1K | 0.01% | 893 |
|
|
2023
Q4 | $509K | Sell |
35,665
-619
| -2% | -$8.83K | 0.01% | 839 |
|
|
2023
Q3 | $560K | Buy |
36,284
+421
| +1% | +$6.5K | 0.01% | 769 |
|
|
2023
Q2 | $549K | Sell |
35,863
-2,935
| -8% | -$44.9K | 0.01% | 817 |
|
|
2023
Q1 | $640K | Sell |
38,798
-3,481
| -8% | -$57.4K | 0.02% | 723 |
|
|
2022
Q4 | $659K | Buy |
42,279
+2,760
| +7% | +$43K | 0.02% | 687 |
|
|
2022
Q3 | $513K | Buy |
39,519
+5,229
| +15% | +$67.9K | 0.01% | 765 |
|
|
2022
Q2 | $482K | Sell |
34,290
-430
| -1% | -$6.04K | 0.01% | 822 |
|
|
2022
Q1 | $497K | Sell |
34,720
-740
| -2% | -$10.6K | 0.01% | 901 |
|
|
2021
Q4 | $483K | Buy |
35,460
+170
| +0.5% | +$2.32K | 0.01% | 908 |
|
|
2021
Q3 | $578K | Buy |
35,290
+1,860
| +6% | +$30.5K | 0.01% | 850 |
|
|
2021
Q2 | $563K | Buy |
33,430
+130
| +0.4% | +$2.19K | 0.01% | 855 |
|
|
2021
Q1 | $608K | Sell |
33,300
-10,250
| -24% | -$187K | 0.02% | 801 |
|
|
2020
Q4 | $793K | Buy |
43,550
+3,560
| +9% | +$64.8K | 0.02% | 640 |
|
|
2020
Q3 | $713K | Sell |
39,990
-1,160
| -3% | -$20.7K | 0.02% | 639 |
|
|
2020
Q2 | $738K | Buy |
+41,150
| New | +$738K | 0.02% | 629 |
|